Atezolizumab is under clinical development by F. Hoffmann-La Roche and currently in Phase III for Muscle Invasive Bladder Cancer (MIBC).
Atezolizumab is under clinical development by F. Hoffmann-La Roche and currently in Phase II for Nasopharyngeal Cancer.
The Centers for Medicare and Medicaid Services on Friday released detailed but heavily redacted explanations of how it ...
Generic drug firm Viatris announced Monday that one of its India-based manufacturing facilities has been placed on import ...
Newer PCSK9 inhibitor drugs can drop levels even further. Someone in the United States dies from heart disease every 33 seconds. It remains the number one killer in the country. So it’s no ...
From 2017 to 2020, it increased to 41.9%. Prescription weight loss medication has become extremely popular because it is easy to take and effective. But, it is expensive, and people must also try ...
Guangshengtang said that nerecovir is a new type of hepatitis B core protein or nucleocapsid modulator, which belongs to a new class of anti-hepatitis B virus drugs under development with a new ...
Emerging research suggests that GLP-1 drugs — Zepbound is one such treatment — not only reduce food cravings but may also suppress desires for other substances. Yet, so far, no pharma ...
With cold and flu season in full swing, a pharmacist has revealed which medications to avoid. Dr Grant Harting, a licensed pharmacist and founder of CrushCost, puts Theraflu at the top of his list.
It may then be wise to listen to doctors’ advice about boosting one’s immune system before leaving home, taking precautions while traveling and using the best procedures to carry medications.
Transgender people are stockpiling medications, worried that their access to gender transition care will be cut off. Trump has vowed to prohibit gender transition care for children and eliminate ...
The packaging and the price are the only differences. This medication typically begins working after about 30 minutes and lasts for about 4 to 6 hours. It’s best to take this medication at ...